source
- Study uncovers tau’s role in reversing mitochondrial electron flow, offering new Alzheimer’s drug targetA Stanford-led research team has identified a previously unknown way that the protein tau disrupts cellular function, adding to its status as a leading target in Alzheimer’s drug development. The…
- FDA approves Takeda’s narcolepsy drug and the first mRNA flu vaccineThe U.S. Food and Drug Administration has granted approval to a new narcolepsy treatment developed by Takeda, marking a significant addition to the therapeutic options for the sleep disorder. In a…